期刊文献+

北京地区儿童鼻咽部肺炎链球菌对大环内酯类抗生素耐药的检测 被引量:9

Macrolide-resistant Streptococcus pneumoniae in the pediatric population in Beijing
原文传递
导出
摘要 目的 研究北京地区儿童携带肺炎链球菌 (SP)对大环内酯类抗生素的耐药特点。方法 对 2 0 0 2~ 2 0 0 3年上呼吸道感染儿童鼻咽部 2 0 0株SP分离株对 4种大环内酯类抗生素、青霉素和克林霉素的最低抑菌浓度进行检测 ;耐药诱导试验分析部分耐药菌株大环内酯类耐药表型 ;PCR检测红霉素耐药基因ermB和mefA。结果  2 0 0株SP中 179株对红霉素耐药。红霉素和青霉素的药敏结果无明显关连性。耐红霉素的 14 7株SP中 ,阿奇霉素、克拉霉素、乙酰螺旋霉素和克林霉素的耐药率分别是 10 0 % ,10 0 % ,95 2 % ,95 9%。耐药表型以结构型大环内酯类、林可酰胺类和链阳性菌素B耐药表型 (cMLS)为主 ,占红霉素耐药株的 95 9%。耐药基因检测中 ,仅携带ermB基因的菌株为 79 6 % ,同时携带ermB和mefA基因菌株为 17 7% ,仅携带mefA基因的菌株为 2 7%。结论 2 0 0 2~ 2 0 0 3年北京上呼吸道感染患儿携带的SP对红霉素耐药率达 89 5 % ,分离株在对红霉素耐药同时也对其他大环内酯类药物和克林霉素耐药。耐大环内酯SP表型以cMLS为主 ,基因型以ermB为主。 Objective To analyze the mechanisms of macrolide resistance in Streptococcus pneumoniae from children in Beijing. Methods The MICs of penicillin and erythromycin were determined by the E-test methods for 200 Streptococcus pneumoniae isolates collected from 2002 to 2003 at Beijing Children′s Hospital. MICs of azithrhomycin, clarithromycin, acetylspiramycin and clindamycin for 147 erythromycin-resistant isolates were detected by the agar dilution methods. For phenotyping, macrolide resistance induction tests were used in erythromycin-resistant isolates. PCR was used to determine the presence of the erythromycin-resistant genes. Results Of 200 Streptococcus pneumoniae isolates, 89.5% were resistant to erythromycin. In 147 erythromycin-resistant isolates, resistance rates were as follows: azithromycin, 100%; clarithromycin, 100%; acetylspiramycin, 95.2%; and clindamycin, 95.9%. The most common macrolide resistance phenotype was the cMIS phenotype (95.9%), 1.4% had the iMLS phenotype and 2.7% the M phenotype. Erythromycin-resistant isolates were characterized for the underlying resistance genotype, with 79.6% having the ermB genotypes, 17.7% having both ermB and mefA, 2.7% having the mefA, and none having neither ermB nor mefA genotypes. Conclusions The rates of carriage of macrolide-resistant Streptococcus pneumoniae by children were high in Beijing during 2002-2003. cMLS was the most prevalent phenotype among erythromycin- resistant Streptococcus pneumoniae islates, and ribosomal modification (ermB gene coded) was the main resistance mechanism against macrolides in Beijing region.
出处 《中华儿科杂志》 CAS CSCD 北大核心 2004年第12期936-939,i003,共5页 Chinese Journal of Pediatrics
基金 国家自然科学基金资助项目 (3 0 2 713 77) 首都医学发展科研基金资助项目
关键词 红霉素 携带 耐药表型 鼻咽部 大环内酯类抗生素 克林霉素 肺炎链球菌 分离株 北京地区 菌株 Streptococcus pneumoniae Macrolides Drug resistance,bacterial
  • 相关文献

参考文献15

  • 1Montanari MP, Mingoia M,Giovanetti E, et al. Differentiation of resistance phenotypes among erythromycin-resistance pneumococci. J Clin Microbiol, 2001,39: 1311-1315.
  • 2Descheemaeker P, Chapelle S, Lammens C,et al. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. J Antimicrob Chemother,2000,45:167-173.
  • 3Lee NY,Song JH,Kim SG,et al.Carriage of antibiotic-resistant pneumococci among Asian children:a multinational surveillance by the Asian network for surveillance of resistant pathogens(ANSORP).Clin Infect Dis,2001,32:1463.
  • 4Kimura T, Horii T, Morita M,et al. Detection of macrolide resistance in Streptococcus pneumoniae. Chemotherapy, 2003,49:56-61.
  • 5Reinert RR, Lutticken R, Bryskier A, et al. Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001. Antimicrob Agents Chemother, 2003,47:489-493.
  • 6Low DE, de AJ, Weiss K, et al.Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000. Antimicrob Agents Chemother. 2002 ,46: 1295-1301.
  • 7Lonks JR,Garau J,Gomez L, et al.Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis, 2002,35:556-564.
  • 8Van Kerkhoven D, Peetermans WE, Verbist L, et al. Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or or oral beta-lactams.J Antimicrob Chemother, 2003,51:691-696.
  • 9Pihlajamaki M, Kataja J,Seppala H,et al. Ribomal mutations in Streptococcus pneumoniae clinical isolates. Antimicrob Agents Chemother, 2002,46: 654-658.
  • 10Farrell DJ, Douthwaite S, Morrissey I. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 Study. Antimicrob Agents Chemother, 2003,47:1777-1783.

同被引文献98

引证文献9

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部